JAK2 and acquired polycythemia vera: The presence of the acquired JAK2 V617F somatic point mutation—a single-base substitution resulting in a change from valine to phenylalanine at position 617 in the protein on chromosome 9p [5]—is suspected to be pathognomonic of PV.